Literature DB >> 27872101

Natural Killer Cells to the Attack: Combination Therapy against Neuroblastoma.

Olatz Zenarruzabeitia1, Joana Vitallé1, Itziar Astigarraga2,3,4, Francisco Borrego5,6,7.   

Abstract

TGFβ in the tumor microenvironment diminishes natural killer (NK) cell-mediated anti-disialoganglioside (anti-GD2) mAb elimination of neuroblastoma cells. Consequently, blockade of TGFβ signaling with galunisertib in combination with the anti-GD2 mAb dinutuximab plus adoptively transferred NK cells is a promising tool for the treatment of neuroblastoma. Clin Cancer Res; 23(3); 615-7. ©2016 AACRSee related article by Tran et al., p. 804. ©2016 American Association for Cancer Research.

Entities:  

Mesh：

Substances：

Year:  2016        PMID： 27872101     DOI： 10.1158/1078-0432.CCR-16-2478

Source DB:  PubMed          Journal:  Clin Cancer Res        ISSN： 1078-0432            Impact factor:   12.531


  7 in total

1.  Role of NK Cells in Tumor Progression.

Authors:  Iñigo Terrén; Francisco Borrego
Journal:  Exp Suppl       Date:  2022

2.  Nanoformulation of CCL21 greatly increases its effectiveness as an immunotherapy for neuroblastoma.

Authors:  Brittany J Poelaert; Svetlana Romanova; Shelby M Knoche; Madeline T Olson; Bailee H Sliker; Kaitlin Smits; Brittney L Dickey; Alexandra E J Moffitt-Holida; Benjamin T Goetz; Nuzhat Khan; Lynette Smith; Hamid Band; Aaron M Mohs; Donald W Coulter; Tatiana K Bronich; Joyce C Solheim
Journal:  J Control Release       Date:  2020-07-22       Impact factor: 9.776

3.  OP9 Feeder Cells Are Superior to M2-10B4 Cells for the Generation of Mature and Functional Natural Killer Cells from Umbilical Cord Hematopoietic Progenitors.

Authors:  Lara Herrera; Juan Manuel Salcedo; Silvia Santos; Miguel Ángel Vesga; Francisco Borrego; Cristina Eguizabal
Journal:  Front Immunol       Date:  2017-06-30       Impact factor: 7.561

Review 4.  NK Cell Metabolism and Tumor Microenvironment.

Authors:  Iñigo Terrén; Ane Orrantia; Joana Vitallé; Olatz Zenarruzabeitia; Francisco Borrego
Journal:  Front Immunol       Date:  2019-09-24       Impact factor: 7.561

Review 5.  NK Cell-Based Immunotherapy in Renal Cell Carcinoma.

Authors:  Iñigo Terrén; Ane Orrantia; Idoia Mikelez-Alonso; Joana Vitallé; Olatz Zenarruzabeitia; Francisco Borrego
Journal:  Cancers (Basel)       Date:  2020-01-29       Impact factor: 6.639

6.  Cytokine-induced killer cells/natural killer cells combined with anti-GD2 monoclonal antibody increase cell death rate in neuroblastoma SK-N-SH cells.

Authors:  Chi Zhang; Xilin Xiong; Yang Li; Ke Huang; Ling Liu; Xiaomin Peng; Wenjun Weng
Journal:  Oncol Lett       Date:  2019-10-29       Impact factor: 2.967

7.  Implication of Interleukin-12/15/18 and Ruxolitinib in the Phenotype, Proliferation, and Polyfunctionality of Human Cytokine-Preactivated Natural Killer Cells.

Authors:  Iñigo Terrén; Idoia Mikelez; Irati Odriozola; Andrea Gredilla; Javier González; Ane Orrantia; Joana Vitallé; Olatz Zenarruzabeitia; Francisco Borrego
Journal:  Front Immunol       Date:  2018-04-16       Impact factor: 7.561
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.